City of Hope will present novel cancer treatment approaches and combinations, leading-edge targeted therapies, and supportive care interventions at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 30 to June 3 in Chicago and online.

A collaborative team of researchers led by vision scientists from the School of Veterinary Medicine at the University of Pennsylvania have developed new tools to improve gene therapy in advanced stages of inherited retinal diseases (IRDs) such as retinitis pigmentosa and Leber congenital amaurosis. “This study addresses one of the biggest hurdles in IRD treatment: how to deliver effective gene therapy after a large portion of the retina has already degenerated,” says Raghavi Sudharsan of Penn Vet.

What if the human body contained a natural bioreactor capable of regenerating vital organs? A collaborative team from ​Wenzhou Medical University, Nanjing University, and University of Macau has redefined the spleen’s potential, transforming it into a ​self-sustaining hub for organ regeneration, as published in Science Translational Medicine (May 21). This breakthrough could revolutionize treatments for type 1 diabetes and beyond.